| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | ACSL6 PMS2 ERCC6 ABCA12 SRPRA INO80 ATP10A DNAH1 ACSL1 ABCA6 NAV3 MLH1 UBA6 KIF14 HELZ ABCC2 KIF17 ACSL5 | 3.77e-06 | 614 | 166 | 18 | GO:0140657 |
| GeneOntologyMolecularFunction | protein kinase activator activity | 3.55e-05 | 149 | 166 | 8 | GO:0030295 | |
| GeneOntologyMolecularFunction | kinase activator activity | 5.64e-05 | 159 | 166 | 8 | GO:0019209 | |
| GeneOntologyMolecularFunction | glutathione dehydrogenase (ascorbate) activity | 6.87e-05 | 2 | 166 | 2 | GO:0045174 | |
| GeneOntologyMolecularFunction | methylarsonate reductase activity | 6.87e-05 | 2 | 166 | 2 | GO:0050610 | |
| GeneOntologyMolecularFunction | arachidonate-CoA ligase activity | 8.86e-05 | 11 | 166 | 3 | GO:0047676 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on phosphorus or arsenic in donors | 2.05e-04 | 3 | 166 | 2 | GO:0030613 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor | 2.05e-04 | 3 | 166 | 2 | GO:0030614 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor | 2.05e-04 | 3 | 166 | 2 | GO:0016672 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 2.05e-04 | 3 | 166 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | long-chain fatty acid-CoA ligase activity | 2.39e-04 | 15 | 166 | 3 | GO:0004467 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | PMS2 ERCC6 ABCA12 SRPRA INO80 ATP10A ABCA6 NAV3 MLH1 KIF14 ABCC2 KIF17 | 3.30e-04 | 441 | 166 | 12 | GO:0016887 |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-sulfur bonds | 3.67e-04 | 41 | 166 | 4 | GO:0016877 | |
| GeneOntologyMolecularFunction | oleoyl-CoA ligase activity | 4.08e-04 | 4 | 166 | 2 | GO:0090434 | |
| GeneOntologyMolecularFunction | chromatin binding | ASXL1 ZNF609 ERCC6 HDAC5 KDM3B KAT2A MED1 CREBBP PHC2 STAT5B MEOX1 NFKB1 MLH1 MBD5 HCFC1 CRTC2 | 4.55e-04 | 739 | 166 | 16 | GO:0003682 |
| GeneOntologyMolecularFunction | cadherin binding | DAB2IP ERC1 PKP4 CAPZB CDH19 CDC42EP1 SND1 CTNNA2 MARK2 HCFC1 | 5.59e-04 | 339 | 166 | 10 | GO:0045296 |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 6.72e-04 | 21 | 166 | 3 | GO:0042975 | |
| GeneOntologyMolecularFunction | glutathione disulfide oxidoreductase activity | 6.76e-04 | 5 | 166 | 2 | GO:0015038 | |
| GeneOntologyMolecularFunction | kinase regulator activity | 1.05e-03 | 305 | 166 | 9 | GO:0019207 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DAB2IP ARHGAP24 GBF1 ARHGAP40 TBC1D30 TRIO MCF2L2 DENND1C ARFGEF3 ARHGAP6 EIF2B3 SMAP2 | 1.12e-03 | 507 | 166 | 12 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DAB2IP ARHGAP24 GBF1 ARHGAP40 TBC1D30 TRIO MCF2L2 DENND1C ARFGEF3 ARHGAP6 EIF2B3 SMAP2 | 1.12e-03 | 507 | 166 | 12 | GO:0030695 |
| GeneOntologyMolecularFunction | enzyme activator activity | DAB2IP ARHGAP24 ERCC6 ARHGAP40 TBC1D30 WNK1 ACSL1 ARHGAP6 BRPF1 FGF13 MARK2 SMAP2 CDK5R2 ALK | 1.19e-03 | 656 | 166 | 14 | GO:0008047 |
| GeneOntologyMolecularFunction | fatty acid ligase activity | 1.27e-03 | 26 | 166 | 3 | GO:0015645 | |
| GeneOntologyMolecularFunction | MutSalpha complex binding | 1.40e-03 | 7 | 166 | 2 | GO:0032407 | |
| GeneOntologyMolecularFunction | CoA-ligase activity | 1.43e-03 | 27 | 166 | 3 | GO:0016405 | |
| GeneOntologyMolecularFunction | protein kinase regulator activity | 1.49e-03 | 259 | 166 | 8 | GO:0019887 | |
| GeneOntologyMolecularFunction | general transcription initiation factor binding | 1.99e-03 | 64 | 166 | 4 | GO:0140296 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TRIM46 MICAL1 ABL2 MAP1A CAPZB INO80 TLNRD1 NFKB1 PAK1 NAV3 KIF14 MICAL3 FGF13 CTNNA2 MARK2 KIF17 TNS1 CDK5R2 SNTB2 | 2.01e-03 | 1099 | 166 | 19 | GO:0008092 |
| GeneOntologyMolecularFunction | acid-thiol ligase activity | 2.14e-03 | 31 | 166 | 3 | GO:0016878 | |
| GeneOntologyMolecularFunction | actin binding | MICAL1 ABL2 MAP1A CAPZB INO80 TLNRD1 MICAL3 CTNNA2 TNS1 CDK5R2 SNTB2 | 2.27e-03 | 479 | 166 | 11 | GO:0003779 |
| GeneOntologyMolecularFunction | transcription coregulator activity | ASXL1 HDAC5 TCF20 KDM3B KAT2A MED1 CREBBP LPIN3 YEATS2 SND1 NFKB1 HCFC1 | 2.64e-03 | 562 | 166 | 12 | GO:0003712 |
| GeneOntologyMolecularFunction | rDNA binding | 2.96e-03 | 10 | 166 | 2 | GO:0000182 | |
| GeneOntologyBiologicalProcess | positive regulation of long-chain fatty acid import across plasma membrane | 4.58e-07 | 3 | 160 | 3 | GO:0010747 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | DAB2IP TRIM46 ASXL1 ABL2 MAP1A TRIO NTRK1 CAPZB ID1 MED1 CDH19 ATP10A GRK1 CDC42EP1 PTPRZ1 BARHL2 CFDP1 PAK1 ROBO2 FGF13 EIF2AK4 CTNNA2 MARK2 FLOT1 CDK5R2 BRWD1 | 1.69e-06 | 1194 | 160 | 26 | GO:0000902 |
| GeneOntologyBiologicalProcess | positive regulation of long-chain fatty acid import into cell | 1.82e-06 | 4 | 160 | 3 | GO:0140214 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | MICAL1 KRT7 COL12A1 ABL2 ARHGAP40 MAP1A KRT82 CAPZB DNAJB6 ID1 BAX CDC42EP1 ARHGAP6 SLC9A1 MYLK3 MTOR PAK1 NAV3 KIF14 MICAL3 FGF13 CTNNA2 | 4.96e-06 | 957 | 160 | 22 | GO:0097435 |
| GeneOntologyBiologicalProcess | neuron migration | DAB2IP TRIM46 ZNF609 BAX PTPRZ1 BARHL2 FGF13 CTNNA2 MARK2 CDK5R2 | 8.10e-06 | 218 | 160 | 10 | GO:0001764 |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | DAB2IP ARHGAP24 GBF1 ABL2 ARHGAP40 TRIO NTRK1 ARFGEF3 ARHGAP6 ADRA1A KIF14 FLOT1 | 1.17e-05 | 333 | 160 | 12 | GO:0051056 |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | ABL2 ARHGAP40 MAP1A CAPZB ID1 KAT2A CDC42EP1 ARHGAP6 SLC9A1 MYLK3 MTOR PAK1 NAV3 FGF13 CTNNA2 MARK2 | 1.18e-05 | 579 | 160 | 16 | GO:0051493 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | DAB2IP TRIM46 ACSL6 ARHGAP24 ABL2 TBC1D30 NTRK1 CAPZB ID1 KAT2A CDC42EP1 PTPRG MTOR PTPRZ1 PAK1 ROBO2 FGF13 CTNNA2 MARK2 ALK | 1.24e-05 | 863 | 160 | 20 | GO:0031344 |
| GeneOntologyBiologicalProcess | dendrite development | DAB2IP ABL2 MAP1A ID1 MPDZ CREBBP MTOR PTPRZ1 PAK1 UBA6 CTNNA2 ALK | 1.24e-05 | 335 | 160 | 12 | GO:0016358 |
| GeneOntologyBiologicalProcess | regulation of long-chain fatty acid import across plasma membrane | 1.57e-05 | 7 | 160 | 3 | GO:0010746 | |
| GeneOntologyBiologicalProcess | protein depolymerization | 1.70e-05 | 144 | 160 | 8 | GO:0051261 | |
| GeneOntologyBiologicalProcess | neuron projection development | DAB2IP TRIM46 ACSL6 ERCC6 ABL2 MAP1A TRIO NTRK1 ID1 MPDZ CREBBP PTPRG MTOR PTPRZ1 BARHL2 PAK1 UBA6 ROBO2 FGF13 EIF2AK4 CTNNA2 MARK2 FLOT1 CDK5R2 ALK | 1.92e-05 | 1285 | 160 | 25 | GO:0031175 |
| GeneOntologyBiologicalProcess | neuron development | DAB2IP TRIM46 ACSL6 ERCC6 ABL2 MAP1A TRIO NTRK1 ID1 MPDZ WNK1 CREBBP GRK1 PTPRG MTOR PTPRZ1 BARHL2 PAK1 UBA6 ROBO2 FGF13 EIF2AK4 CTNNA2 MARK2 FLOT1 CDK5R2 ALK | 2.18e-05 | 1463 | 160 | 27 | GO:0048666 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | DAB2IP TRIM46 ACSL6 ARHGAP24 ABL2 TBC1D30 NTRK1 CAPZB ID1 CDC42EP1 PTPRG MTOR PTPRZ1 PAK1 ROBO2 FGF13 CTNNA2 MARK2 ALK | 3.19e-05 | 846 | 160 | 19 | GO:0120035 |
| GeneOntologyBiologicalProcess | response to temperature stimulus | 3.67e-05 | 208 | 160 | 9 | GO:0009266 | |
| GeneOntologyBiologicalProcess | regulation of long-chain fatty acid import into cell | 3.72e-05 | 9 | 160 | 3 | GO:0140212 | |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | ARHGAP40 MAP1A CAPZB ID1 CDC42EP1 ARHGAP6 SLC9A1 MYLK3 MTOR PAK1 NAV3 FGF13 CTNNA2 | 3.88e-05 | 438 | 160 | 13 | GO:1902903 |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane transport | 5.58e-05 | 273 | 160 | 10 | GO:0034764 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | DAB2IP ARHGAP24 GBF1 ABL2 ARHGAP40 TRIO NTRK1 BRAP CDC42EP1 ARFGEF3 ARHGAP6 ADRA1A KIF14 FLOT1 | 8.06e-05 | 538 | 160 | 14 | GO:0007264 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | DAB2IP TRIM46 ACSL6 ABL2 NTRK1 ID1 PTPRG MTOR PTPRZ1 PAK1 ROBO2 FGF13 CTNNA2 MARK2 ALK | 8.71e-05 | 612 | 160 | 15 | GO:0010975 |
| GeneOntologyBiologicalProcess | long-chain fatty acid import across plasma membrane | 9.57e-05 | 12 | 160 | 3 | GO:0015911 | |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | DAB2IP ARHGAP24 ABL2 HDAC5 TBC1D30 ERC1 NTRK1 PKP4 BAX GCKR CREBBP ARHGAP6 ADRA1A SLC9A1 MTOR PAK1 KIF14 FGF13 FGF14 MARK2 FLOT1 GSTO1 CDK5R2 ALK CRTC2 | 1.09e-04 | 1430 | 160 | 25 | GO:0044093 |
| GeneOntologyBiologicalProcess | limbic system development | 1.17e-04 | 141 | 160 | 7 | GO:0021761 | |
| GeneOntologyBiologicalProcess | development of secondary sexual characteristics | 1.24e-04 | 13 | 160 | 3 | GO:0045136 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | DAB2IP ARHGAP24 ARHGAP40 TBC1D30 NTRK1 CAPZB DNAJB6 ID1 BAX KAT2A DNAJC6 CDC42EP1 ARHGAP6 SLC9A1 MTOR PIP4K2A PAK1 NAV3 KIF14 ROBO2 FLOT1 HCFC1 | 1.33e-04 | 1189 | 160 | 22 | GO:0044087 |
| GeneOntologyBiologicalProcess | learning or memory | ABL2 MAP1A NTRK1 KAT2A CREBBP MTOR PTPRZ1 PAK1 UBA6 FGF13 EIF2AK4 | 1.64e-04 | 373 | 160 | 11 | GO:0007611 |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | ABL2 ARHGAP40 CAPZB ID1 CDC42EP1 ARHGAP6 SLC9A1 MYLK3 MTOR PAK1 FGF13 CTNNA2 | 1.64e-04 | 438 | 160 | 12 | GO:0032970 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | DAB2IP TRIM46 ABL2 MAP1A TRIO NTRK1 ID1 PTPRZ1 BARHL2 PAK1 ROBO2 FGF13 EIF2AK4 CTNNA2 MARK2 FLOT1 CDK5R2 | 1.70e-04 | 802 | 160 | 17 | GO:0048812 |
| GeneOntologyBiologicalProcess | regulation of actin cytoskeleton organization | ABL2 ARHGAP40 CAPZB ID1 CDC42EP1 ARHGAP6 SLC9A1 MYLK3 MTOR PAK1 CTNNA2 | 2.11e-04 | 384 | 160 | 11 | GO:0032956 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | DAB2IP TRIM46 ABL2 MAP1A TRIO NTRK1 ID1 PTPRZ1 BARHL2 PAK1 ROBO2 FGF13 EIF2AK4 CTNNA2 MARK2 FLOT1 CDK5R2 | 2.18e-04 | 819 | 160 | 17 | GO:0120039 |
| GeneOntologyBiologicalProcess | regulation of cellular response to heat | 2.38e-04 | 16 | 160 | 3 | GO:1900034 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | DAB2IP TRIM46 ABL2 MAP1A TRIO NTRK1 ID1 PTPRZ1 BARHL2 PAK1 ROBO2 FGF13 EIF2AK4 CTNNA2 MARK2 FLOT1 CDK5R2 | 2.41e-04 | 826 | 160 | 17 | GO:0048858 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | TRIM46 ABL2 MAP1A TRIO NTRK1 ID1 GRK1 PTPRZ1 BARHL2 PAK1 ROBO2 FGF13 CTNNA2 MARK2 FLOT1 CDK5R2 | 2.41e-04 | 748 | 160 | 16 | GO:0048667 |
| GeneOntologyBiologicalProcess | regulation of organelle organization | ABL2 ARHGAP40 TBC1D30 MAP1A ERC1 CAPZB ID1 BAX KAT2A INO80 C2CD5 CDC42EP1 ARHGAP6 SLC9A1 MYLK3 MTOR PIP4K2A YLPM1 PAK1 NAV3 FGF13 CTNNA2 MARK2 | 2.82e-04 | 1342 | 160 | 23 | GO:0033043 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | DAB2IP ACSL6 ABL2 ERC1 NTRK1 ID1 BAX KAT2A INO80 WNK1 ATP10A C2CD5 CDC42EP1 MYLK3 MTOR PTPRZ1 PIP4K2A PAK1 NAV3 ROBO2 MARK2 FLOT1 ALK | 3.62e-04 | 1366 | 160 | 23 | GO:0051130 |
| GeneOntologyBiologicalProcess | response to heat | 3.66e-04 | 121 | 160 | 6 | GO:0009408 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular component organization | TRIM46 ARHGAP24 TBC1D30 MAP1A CAPZB DNAJB6 ID1 KAT2A ARHGAP6 PTPRG MTOR PTPRZ1 NAV3 KIF14 ROBO2 FGF13 CTNNA2 | 4.04e-04 | 864 | 160 | 17 | GO:0051129 |
| GeneOntologyBiologicalProcess | long-chain fatty-acyl-CoA biosynthetic process | 4.05e-04 | 19 | 160 | 3 | GO:0035338 | |
| GeneOntologyBiologicalProcess | protein-containing complex disassembly | 4.60e-04 | 291 | 160 | 9 | GO:0032984 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | DAB2IP ASXL1 ZNF609 ERCC6 HDAC5 TCF20 KAT2A INO80 MED1 CREBBP ATF6B CASZ1 STAT5B MEOX1 KANSL3 LPIN3 SLC9A1 CSRNP3 BARHL2 NFKB1 MGA HCFC1 CRTC2 | 4.63e-04 | 1390 | 160 | 23 | GO:0045944 |
| GeneOntologyBiologicalProcess | long-chain fatty acid import into cell | 4.74e-04 | 20 | 160 | 3 | GO:0044539 | |
| GeneOntologyBiologicalProcess | cognition | ABL2 MAP1A NTRK1 KAT2A CREBBP MTOR PTPRZ1 PAK1 UBA6 FGF13 EIF2AK4 | 4.78e-04 | 423 | 160 | 11 | GO:0050890 |
| GeneOntologyBiologicalProcess | negative regulation of cell projection organization | 4.81e-04 | 233 | 160 | 8 | GO:0031345 | |
| GeneOntologyBiologicalProcess | axonogenesis | TRIM46 MAP1A TRIO NTRK1 PTPRZ1 BARHL2 PAK1 ROBO2 FGF13 CTNNA2 MARK2 FLOT1 CDK5R2 | 4.84e-04 | 566 | 160 | 13 | GO:0007409 |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | DAB2IP ACSL6 ABL2 NTRK1 KAT2A CDC42EP1 MTOR PTPRZ1 PAK1 ROBO2 MARK2 ALK | 4.89e-04 | 494 | 160 | 12 | GO:0031346 |
| GeneOntologyBiologicalProcess | long-term memory | 5.20e-04 | 48 | 160 | 4 | GO:0007616 | |
| GeneOntologyBiologicalProcess | regulation of actin filament organization | 5.73e-04 | 300 | 160 | 9 | GO:0110053 | |
| GeneOntologyBiologicalProcess | sulfur compound metabolic process | ACSL6 MICAL1 GSTO2 STAT5B ACSL1 PXYLP1 CHST2 ABCC2 GSTO1 ACSL5 | 5.79e-04 | 365 | 160 | 10 | GO:0006790 |
| GeneOntologyBiologicalProcess | fatty acid transmembrane transport | 6.33e-04 | 22 | 160 | 3 | GO:1902001 | |
| GeneOntologyBiologicalProcess | positive regulation of dendrite development | 6.33e-04 | 22 | 160 | 3 | GO:1900006 | |
| GeneOntologyBiologicalProcess | actin filament organization | MICAL1 ABL2 ARHGAP40 CAPZB ID1 CDC42EP1 ARHGAP6 SLC9A1 MTOR PAK1 MICAL3 CTNNA2 | 6.36e-04 | 509 | 160 | 12 | GO:0007015 |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | CELF4 MAP1A TRIO ERC1 NTRK1 KAT2A WNK1 ADRA1A MTOR PAK1 FGF14 EIF2AK4 SLC24A1 FLOT1 | 6.75e-04 | 663 | 160 | 14 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | CELF4 MAP1A TRIO ERC1 NTRK1 KAT2A WNK1 ADRA1A MTOR PAK1 FGF14 EIF2AK4 SLC24A1 FLOT1 | 6.85e-04 | 664 | 160 | 14 | GO:0099177 |
| GeneOntologyBiologicalProcess | triglyceride biosynthetic process | 7.07e-04 | 52 | 160 | 4 | GO:0019432 | |
| GeneOntologyBiologicalProcess | actin filament bundle assembly | 7.41e-04 | 191 | 160 | 7 | GO:0051017 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection development | 7.44e-04 | 249 | 160 | 8 | GO:0010976 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | ASXL1 ERCC6 HDAC5 KDM3B NASP KAT2A INO80 MED1 TRIP12 CREBBP KANSL3 YEATS2 GTF2E1 UBN1 BRPF1 CFDP1 PAK1 HCFC1 | 7.66e-04 | 999 | 160 | 18 | GO:0071824 |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 1.08e-04 | 94 | 167 | 6 | GO:0000123 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 1.89e-04 | 104 | 167 | 6 | GO:0031248 | |
| GeneOntologyCellularComponent | MutLalpha complex | 1.89e-04 | 3 | 167 | 2 | GO:0032389 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 2.44e-04 | 109 | 167 | 6 | GO:1902493 | |
| GeneOntologyCellularComponent | chromatin | TBX22 BNC2 ERCC6 HDAC5 KDM3B NASP KAT2A INO80 MED1 CREBBP ATF6B CASZ1 PHC2 STAT5B MEOX1 HOXA3 KANSL3 YEATS2 CSRNP3 BARHL2 BRPF1 NFKB1 CFDP1 MGA HCFC1 | 3.00e-04 | 1480 | 167 | 25 | GO:0000785 |
| GeneOntologyCellularComponent | postsynapse | CELF4 ABL2 MAP1A TRIO ERC1 PKP4 KCTD8 CAPZB MPDZ NBEA DNAJC6 ADRA1A MTOR PTPRZ1 PAK1 ROBO2 CTNNA2 MARK2 KIF17 | 5.15e-04 | 1018 | 167 | 19 | GO:0098794 |
| Domain | Bromodomain_CS | 7.54e-05 | 26 | 165 | 4 | IPR018359 | |
| Domain | GST_omega | 7.76e-05 | 2 | 165 | 2 | IPR005442 | |
| Domain | BROMODOMAIN_1 | 3.09e-04 | 37 | 165 | 4 | PS00633 | |
| Domain | Bromodomain | 3.43e-04 | 38 | 165 | 4 | PF00439 | |
| Domain | DNA_MISMATCH_REPAIR_1 | 4.60e-04 | 4 | 165 | 2 | PS00058 | |
| Domain | DNA_mismatch_repair_C | 4.60e-04 | 4 | 165 | 2 | IPR013507 | |
| Domain | DNA_mismatch_repair_fam | 4.60e-04 | 4 | 165 | 2 | IPR002099 | |
| Domain | DNA_mis_repair | 4.60e-04 | 4 | 165 | 2 | PF01119 | |
| Domain | BROMODOMAIN_2 | 4.61e-04 | 41 | 165 | 4 | PS50014 | |
| Domain | Bromodomain | 5.06e-04 | 42 | 165 | 4 | IPR001487 | |
| Domain | BROMO | 5.06e-04 | 42 | 165 | 4 | SM00297 | |
| Domain | - | 5.06e-04 | 42 | 165 | 4 | 1.20.920.10 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | GBF1 ABL2 TCF20 TTC28 TRIO ERC1 KCTD8 CAPZB DNAJB6 KDM3B MPDZ WNK1 TRIP12 CDC42EP1 LPIN3 ARFGEF3 STOX2 MYLK3 MTOR KIF14 HELZ MARK2 SMAP2 SH3RF3 CRTC2 | 9.66e-13 | 861 | 170 | 25 | 36931259 |
| Pubmed | DAB2IP TRIM46 ARHGAP24 TCF20 TRIO TCOF1 ERC1 PKP4 MPDZ NBEA ARMCX4 DNAJC6 ATF6B STOX2 FAM120A MTOR YLPM1 SEC23IP PAK1 UBA6 MIOS CTNNA2 MGA TNS1 PRRC2B | 1.09e-11 | 963 | 170 | 25 | 28671696 | |
| Pubmed | TCF20 TTC28 TCOF1 ERC1 CAPZB KDM3B NASP MPDZ MED1 CREBBP BRAP YEATS2 SND1 YLPM1 SEC23IP KIF14 MGA HCFC1 PRRC2B | 3.28e-11 | 549 | 170 | 19 | 38280479 | |
| Pubmed | ZNF609 ERCC6 MAP1A TTC28 TCOF1 ABCA12 ERC1 PKP4 DNAJB6 KAT2A INO80 CREBBP C2CD5 CDC42EP1 YEATS2 FAM120A ZNF608 BRPF1 PIP4K2A RTL9 MLH1 HELZ MGA PRRC2B BRWD1 | 2.41e-10 | 1116 | 170 | 25 | 31753913 | |
| Pubmed | DAB2IP PMS2 ZNF609 TRIO ERC1 PKP4 BAX SRPRA NBEA CDC42EP1 GTF2E1 PTPRG PTPRZ1 NFKB1 YLPM1 MLH1 MIOS KIF14 HELZ MICAL3 EIF2AK4 TNS1 SNTB2 PRRC2B | 3.76e-10 | 1049 | 170 | 24 | 27880917 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | ZNF609 MAP1A RTF2 KDM3B SRPRA MED1 CREBBP KANSL3 YEATS2 GTF2E1 UBN1 ZNF608 PAK1 LSM14B MGA HCFC1 | 7.10e-10 | 444 | 170 | 16 | 34795231 |
| Pubmed | GBF1 HDAC5 TTC28 ERC1 PKP4 MPDZ SRPRA WNK1 C2CD5 CDC42EP1 KIF14 HELZ MARK2 SH3RF3 SNTB2 CRTC2 | 7.58e-10 | 446 | 170 | 16 | 24255178 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | DAB2IP ZNF609 HDAC5 ERC1 CAPZB CHCHD6 MED1 WNK1 CREBBP URGCP ACSL1 LPIN3 PTPRG SND1 MTOR NFKB1 RTL9 EIF2B3 SEC23IP MIOS HELZ MARK2 SMAP2 SH3RF3 PRRC2B CRTC2 | 1.57e-09 | 1321 | 170 | 26 | 27173435 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ZNF609 GBF1 MAP1A ERC1 SRPRA INO80 MED1 TRIP12 FAM120A SND1 BRPF1 PIP4K2A YLPM1 HELZ LSM14B MGA SMAP2 NNT PRRC2B | 3.27e-09 | 724 | 170 | 19 | 36232890 |
| Pubmed | ZNF609 TTC28 PKP4 KDM3B MPDZ SRPRA URGCP STAT5B LPIN3 FAM120A MLH1 HELZ MICAL3 EIF2AK4 MARK2 HCFC1 PRRC2B CRTC2 | 3.80e-09 | 650 | 170 | 18 | 38777146 | |
| Pubmed | ZNF609 TCF20 TTC28 TRIO KDM3B AKAP3 MPDZ SRPRA WNK1 BRAP YEATS2 FAM120A YLPM1 SEC23IP MIOS KIF14 HELZ MGA HCFC1 | 4.00e-09 | 733 | 170 | 19 | 34672954 | |
| Pubmed | ZNF609 TCF20 KDM3B MED1 CREBBP CASZ1 KANSL3 ZNF608 YLPM1 MGA HCFC1 PRRC2B | 9.53e-09 | 268 | 170 | 12 | 33640491 | |
| Pubmed | DAB2IP ACSL6 ASXL1 HDAC5 TCF20 TTC28 ERC1 DNAJC6 ARFGEF3 YEATS2 NAV3 MICAL3 KIF17 PRRC2B | 1.54e-08 | 407 | 170 | 14 | 12693553 | |
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 2.23e-08 | 134 | 170 | 9 | 25452129 | |
| Pubmed | DAB2IP PMS2 ERCC6 TCOF1 ERC1 NASP MED1 WNK1 TRIP12 STAT5B FAM120A PAK1 MARK2 HCFC1 SNTB2 | 3.07e-08 | 503 | 170 | 15 | 16964243 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | HDAC5 MAP1A TTC28 TCOF1 ERC1 WNK1 CREBBP BRAP KANSL3 ARFGEF3 YEATS2 UBN1 PIP4K2A KIF14 HELZ PRRC2B | 3.72e-08 | 588 | 170 | 16 | 38580884 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | GBF1 TCF20 TCOF1 KDM3B NASP MED1 TRIP12 URGCP C2CD5 PHC2 KANSL3 YEATS2 UBN1 BRPF1 YLPM1 HELZ MICAL3 MARK2 | 5.44e-08 | 774 | 170 | 18 | 15302935 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ERCC6 TCF20 KDM3B NASP INO80 MED1 TRIP12 CASZ1 GTF2E1 UBN1 BRPF1 CFDP1 MLH1 MGA HCFC1 BRWD1 | 5.87e-08 | 608 | 170 | 16 | 36089195 |
| Pubmed | PMS2 TTC28 ERC1 NASP MED1 WNK1 TRIP12 CREBBP PHC2 UBN1 ZNF608 PIP4K2A KIF14 MICAL3 FLOT1 GSTO1 | 1.31e-07 | 645 | 170 | 16 | 25281560 | |
| Pubmed | ASXL1 ZNF609 HDAC5 TCF20 KAT2A INO80 CREBBP STAT5B KANSL3 YEATS2 FAM120A UBN1 ZNF608 NFKB1 YLPM1 CFDP1 HELZ LSM14B FLOT1 MGA SMAP2 HCFC1 SNTB2 PRRC2B | 1.40e-07 | 1429 | 170 | 24 | 35140242 | |
| Pubmed | DAB2IP ABL2 MAP1A PKP4 NBEA DNAJC6 C2CD5 PAK1 MICAL3 CTNNA2 MARK2 SNTB2 | 1.61e-07 | 347 | 170 | 12 | 17114649 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | ZNF609 GBF1 HDAC5 MAP1A TCOF1 WNK1 TRIP12 ARHGAP6 UBN1 YLPM1 PAK1 MGA CRTC2 | 2.26e-07 | 430 | 170 | 13 | 35044719 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DAB2IP GBF1 TRIO KDM3B KAT2A INO80 WNK1 CASZ1 PHC2 KANSL3 LPIN3 TLNRD1 UBN1 SND1 MTOR EIF2B3 MICAL3 MBD5 HCFC1 PRRC2B | 5.34e-07 | 1105 | 170 | 20 | 35748872 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | ELOC ASXL1 TTC28 TCOF1 CAPZB KDM3B MPDZ KAT2A USP37 TRIP12 USP2 SND1 YLPM1 MIOS EIF2AK4 MARK2 HCFC1 SNTB2 PRRC2B | 5.49e-07 | 1005 | 170 | 19 | 19615732 |
| Pubmed | TRIM46 ACSL6 MICAL1 MAP1A TRIO ERC1 PKP4 CAPZB DNAJB6 NBEA DNAJC6 FAM120A SND1 PTPRZ1 PIP4K2A MIOS MICAL3 FGF13 CTNNA2 MARK2 FLOT1 TNS1 PRRC2B | 5.61e-07 | 1431 | 170 | 23 | 37142655 | |
| Pubmed | PMS2 ZNF609 TCF20 MAP1A TRIO MED1 KANSL3 YEATS2 GTF2E1 MLH1 KIF14 LSM14B GSTO1 | 6.48e-07 | 472 | 170 | 13 | 38943005 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MAP1A TCOF1 ERC1 KDM3B NASP MED1 WNK1 BRAP YEATS2 GTF2E1 SND1 YLPM1 SEC23IP CFDP1 MLH1 HELZ HCFC1 PRRC2B | 8.46e-07 | 934 | 170 | 18 | 33916271 |
| Pubmed | ABL2 TCF20 MAP1A WNK1 CREBBP CDC42EP1 SLC9A1 PAK1 NAV3 HELZ MBD5 MGA TNS1 | 8.98e-07 | 486 | 170 | 13 | 20936779 | |
| Pubmed | Acetylation of MLH1 by CBP increases cellular DNA mismatch repair activity. | 1.14e-06 | 5 | 170 | 3 | 37094360 | |
| Pubmed | Revised nomenclature for the mammalian long-chain acyl-CoA synthetase gene family. | 1.14e-06 | 5 | 170 | 3 | 15292367 | |
| Pubmed | 1.14e-06 | 5 | 170 | 3 | 24269233 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | CELF5 DPYD ERCC6 NASP SRPRA NBEA TRIP12 UBA6 MICAL3 EIF2AK4 MARK2 SH3RF3 HCFC1 | 1.15e-06 | 497 | 170 | 13 | 36774506 |
| Pubmed | PMS2 TTC28 TRIO TCOF1 ERC1 MCF2L2 NASP NBEA ARMCX4 TRIP12 CREBBP STAT5B USP2 FAM120A YLPM1 SEC23IP PAK1 NAV3 ANKRD36 FLOT1 BRWD1 | 1.40e-06 | 1285 | 170 | 21 | 35914814 | |
| Pubmed | ELAPOR2 PMS2 COL12A1 GBF1 TRIO CAPZB URGCP GARIN3 UBN1 NFKB1 ROBO2 MBD5 FLOT1 MGA PRRC2B | 1.67e-06 | 689 | 170 | 15 | 36543142 | |
| Pubmed | 1.81e-06 | 225 | 170 | 9 | 12168954 | ||
| Pubmed | ABL2 TTC28 TCOF1 ERC1 CAPZB DNAJB6 MPDZ SRPRA CDC42EP1 SND1 SEC23IP UBA6 MICAL3 MARK2 HCFC1 | 2.33e-06 | 708 | 170 | 15 | 39231216 | |
| Pubmed | ELOC TCF20 RTF2 DNAJB6 KDM3B KAT2A INO80 MED1 CREBBP PHC2 KANSL3 GTF2E1 UBN1 SND1 YLPM1 CFDP1 UBA6 HCFC1 | 2.69e-06 | 1014 | 170 | 18 | 32416067 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | ELAPOR2 GLT8D2 ASXL1 KRT7 CELF4 GBF1 CAPZB DENND1C GSTO2 USP37 CDH19 IL22RA1 GARIN3 RNF125 MTOR NFKB1 ENTPD6 PXYLP1 GIMAP6 PRRC2B | 3.18e-06 | 1242 | 170 | 20 | 30973865 |
| Pubmed | Large-scale structural analysis of the classical human protein tyrosine phosphatome. | 3.42e-06 | 47 | 170 | 5 | 19167335 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ZNF609 TRIO RTF2 CHCHD6 ATP10A CREBBP CASZ1 STAT5B DNAH1 KANSL3 ARFGEF3 YEATS2 ARHGAP6 FAM120A PTPRG ZNF608 UBA6 MICAL3 FGF13 EIF2AK4 MBD5 SH3RF3 | 3.95e-06 | 1489 | 170 | 22 | 28611215 |
| Pubmed | 3.96e-06 | 7 | 170 | 3 | 17197235 | ||
| Pubmed | ELOC PMS2 GBF1 TCOF1 KDM3B CHCHD6 USP37 TRIP12 URGCP BRAP GTF2E1 UBA6 | 4.87e-06 | 481 | 170 | 12 | 28190767 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | ABL2 TTC28 TRIO ERC1 PKP4 CAPZB DNAJB6 FAM120A BRPF1 NFKB1 KIF14 MICAL3 FLOT1 MGA PRRC2B BRWD1 | 5.00e-06 | 853 | 170 | 16 | 28718761 |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | ELOC ASXL1 REXO5 DNAJB6 INO80 TRIP12 PHC2 KANSL3 YEATS2 MBD5 MGA HCFC1 | 6.50e-06 | 495 | 170 | 12 | 27705803 |
| Pubmed | 9.47e-06 | 209 | 170 | 8 | 36779422 | ||
| Pubmed | 1.10e-05 | 281 | 170 | 9 | 24163370 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 1.10e-05 | 281 | 170 | 9 | 28706196 | |
| Pubmed | 1.10e-05 | 153 | 170 | 7 | 10718198 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.16e-05 | 283 | 170 | 9 | 30585729 | |
| Pubmed | ARHGAP24 ARHGAP40 TRIO PKP4 MCF2L2 DNAJB6 NASP MPDZ SRPRA NBEA ARHGAP6 BRPF1 PAK1 FLOT1 MGA SNTB2 | 1.21e-05 | 916 | 170 | 16 | 32203420 | |
| Pubmed | 1.30e-05 | 157 | 170 | 7 | 30186101 | ||
| Pubmed | 1.33e-05 | 288 | 170 | 9 | 23383273 | ||
| Pubmed | ELOC GBF1 RBMXL3 TCOF1 SRPRA MED1 TRIP12 PHC2 ANKRD36B KANSL3 FAM120A YLPM1 EIF2AK4 CTNNA2 MARK2 LSM14B FLOT1 ALK HCFC1 PRRC2B | 1.35e-05 | 1371 | 170 | 20 | 36244648 | |
| Pubmed | ELOC ERCC6 TBC1D30 PKP4 MPDZ SRPRA KAT2A INO80 MED1 CASZ1 PHC2 SLC9A1 SND1 MLH1 MIOS KIF14 HELZ CTNNA2 MARK2 LSM14B SNTB2 | 1.46e-05 | 1497 | 170 | 21 | 31527615 | |
| Pubmed | TCF20 TTC28 KDM3B MUC16 NBEA MED1 CREBBP CASZ1 ANKRD36B YEATS2 SEC23IP SNTB2 PRRC2B | 1.69e-05 | 638 | 170 | 13 | 31182584 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 25871621 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 33860440 | ||
| Pubmed | Assessing pathogenicity of MLH1 variants by co-expression of human MLH1 and PMS2 genes in yeast. | 2.38e-05 | 2 | 170 | 2 | 19863800 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 10429667 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 19513904 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 12496485 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 33835601 | ||
| Pubmed | A role for the MHC class I-like Mill molecules in nutrient metabolism and wound healing. | 2.38e-05 | 2 | 170 | 2 | 18560379 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 29175432 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 28334733 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 23917076 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 33054526 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 12569559 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 18317225 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 17405917 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 12810663 | ||
| Pubmed | Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia. | 2.38e-05 | 2 | 170 | 2 | 12714493 | |
| Pubmed | Conservation of functional asymmetry in the mammalian MutLα ATPase. | 2.38e-05 | 2 | 170 | 2 | 20864418 | |
| Pubmed | [Expression of MICA/B protein in esophageal cancer and its clinical significance]. | 2.38e-05 | 2 | 170 | 2 | 23291067 | |
| Pubmed | Mylk3 null C57BL/6N mice develop cardiomyopathy, whereas Nnt null C57BL/6J mice do not. | 2.38e-05 | 2 | 170 | 2 | 32213617 | |
| Pubmed | [The polymorphism distributions of MICA and MICB microsatellite in Guangdong Han population]. | 2.38e-05 | 2 | 170 | 2 | 15192843 | |
| Pubmed | MICA, MICB Polymorphisms and Linkage Disequilibrium with HLA-B in a Chinese Mongolian Population. | 2.38e-05 | 2 | 170 | 2 | 27028549 | |
| Pubmed | Contribution of human mlh1 and pms2 ATPase activities to DNA mismatch repair. | 2.38e-05 | 2 | 170 | 2 | 11897781 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 19635583 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 29665245 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 26895986 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 28925058 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 24173243 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 19672700 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 25726706 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 12466900 | ||
| Pubmed | Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. | 2.38e-05 | 2 | 170 | 2 | 9497295 | |
| Pubmed | MICB microsatellite polymorphism is associated with ulcerative colitis in Chinese population. | 2.38e-05 | 2 | 170 | 2 | 16679067 | |
| Pubmed | MICA/B expression in macrophage foam cells infiltrating atherosclerotic plaques. | 2.38e-05 | 2 | 170 | 2 | 24997223 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 28677817 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 21388352 | ||
| Pubmed | In vivo expression pattern of MICA and MICB and its relevance to auto-immunity and cancer. | 2.38e-05 | 2 | 170 | 2 | 17565371 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 19949079 | ||
| Pubmed | Direct visualization of asymmetric adenine-nucleotide-induced conformational changes in MutL alpha. | 2.38e-05 | 2 | 170 | 2 | 18206974 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 16776673 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 19553547 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 27221910 | ||
| Pubmed | Dimerization of MLH1 and PMS2 limits nuclear localization of MutLalpha. | 2.38e-05 | 2 | 170 | 2 | 12697830 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 18941778 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 9770516 | ||
| Interaction | PML interactions | PMS2 ZNF609 ERCC6 MAP1A NTRK1 RTF2 KDM3B CHCHD6 SRPRA MED1 CDH19 CREBBP KANSL3 ACSL1 YEATS2 USP2 GTF2E1 FAM120A RNF125 UBN1 ZNF608 MTOR NFKB1 PAK1 MLH1 KIF14 LSM14B GSTO1 HCFC1 | 8.19e-10 | 933 | 168 | 29 | int:PML |
| Interaction | YWHAH interactions | DAB2IP GBF1 ABL2 HDAC5 TCF20 TTC28 TRIO ERC1 NTRK1 CAPZB DNAJB6 KDM3B MPDZ MED1 WNK1 TRIP12 CREBBP CDC42EP1 LPIN3 ARFGEF3 STOX2 MTOR KIF14 MARK2 SMAP2 SH3RF3 CRTC2 | 4.44e-07 | 1102 | 168 | 27 | int:YWHAH |
| Interaction | UBAP2L interactions | NTRK1 CAPZB KAT2A YEATS2 FAM120A MTOR MLH1 KIF14 HELZ LSM14B SMAP2 HCFC1 PRRC2B | 1.36e-06 | 298 | 168 | 13 | int:UBAP2L |
| Interaction | PPIA interactions | DCAF15 ASXL1 PMS2 ZNF609 ERCC6 HDAC5 TCF20 MAP1A TRIO NTRK1 CAPZB GCKR MED1 KANSL3 YEATS2 GTF2E1 PTPRG MLH1 KIF14 ANKRD36 LSM14B GSTO1 HCFC1 | 1.38e-06 | 888 | 168 | 23 | int:PPIA |
| Interaction | PICALM interactions | NTRK1 CAPZB DNAJB6 WNK1 DNAJC6 ATF6B KIF14 MICAL3 ABCC2 FLOT1 SMAP2 PRRC2B | 2.21e-06 | 263 | 168 | 12 | int:PICALM |
| Interaction | CDH19 interactions | 4.57e-06 | 30 | 168 | 5 | int:CDH19 | |
| Interaction | YY1 interactions | ASXL1 HDAC5 CAPZB BAX KAT2A INO80 TRIP12 CREBBP KANSL3 YEATS2 MTOR NFKB1 PIP4K2A MGA HCFC1 | 6.42e-06 | 454 | 168 | 15 | int:YY1 |
| Interaction | KANSL3 interactions | 7.63e-06 | 86 | 168 | 7 | int:KANSL3 | |
| Interaction | MAX interactions | REXO5 TCOF1 MCF2L2 KAT2A USP37 UBN1 SND1 MTOR PIP4K2A MGA HCFC1 | 8.69e-06 | 251 | 168 | 11 | int:MAX |
| Interaction | IL1RL2 interactions | 1.02e-05 | 17 | 168 | 4 | int:IL1RL2 | |
| Interaction | IMPDH2 interactions | ELOC ASXL1 GBF1 HDAC5 TTC28 ERC1 NTRK1 CAPZB WNK1 STAT5B NFKB1 SEC23IP UBA6 KIF14 | 1.20e-05 | 420 | 168 | 14 | int:IMPDH2 |
| Interaction | RUVBL2 interactions | ASXL1 PMS2 HDAC5 NTRK1 CAPZB INO80 YEATS2 MTOR NFKB1 SEC23IP CFDP1 PAK1 MLH1 KIF14 MGA SMAP2 HCFC1 | 1.62e-05 | 616 | 168 | 17 | int:RUVBL2 |
| Interaction | H3-3A interactions | ERCC6 HDAC5 TCF20 KDM3B NASP KAT2A INO80 MED1 TRIP12 CREBBP CASZ1 GTF2E1 UBN1 BRPF1 CFDP1 MLH1 MGA HCFC1 BRWD1 | 1.64e-05 | 749 | 168 | 19 | int:H3-3A |
| Interaction | HNF4A interactions | ZNF609 HDAC5 MUC19 KAT2A MED1 CREBBP KANSL3 YEATS2 UBN1 ZNF608 MGA | 2.04e-05 | 275 | 168 | 11 | int:HNF4A |
| Interaction | RHOQ interactions | ABL2 PKP4 C2CD5 CDC42EP1 ARFGEF3 SLC9A1 PTPRG MTOR PAK1 KIF14 MICAL3 MARK2 FLOT1 SNTB2 | 2.11e-05 | 442 | 168 | 14 | int:RHOQ |
| Interaction | DDB1 interactions | ELOC DCAF15 ASXL1 PMS2 ARHGAP24 ERCC6 HDAC5 NTRK1 CAPZB KAT2A INO80 MED1 CREBBP BRAP MTOR PAK1 KIF14 BRWD1 | 2.19e-05 | 697 | 168 | 18 | int:DDB1 |
| Interaction | PHOX2A interactions | 3.09e-05 | 8 | 168 | 3 | int:PHOX2A | |
| Interaction | POU5F1 interactions | ELOC TCF20 TCOF1 ERC1 MUC16 INO80 YEATS2 GTF2E1 GARIN3 SND1 HELZ LSM14B MGA HCFC1 PRRC2B BRWD1 | 3.18e-05 | 584 | 168 | 16 | int:POU5F1 |
| Interaction | SETD1B interactions | 3.84e-05 | 75 | 168 | 6 | int:SETD1B | |
| Interaction | YWHAG interactions | DAB2IP GBF1 ABL2 HDAC5 TTC28 ERC1 NTRK1 CAPZB DNAJB6 KDM3B MPDZ USP37 WNK1 TRIP12 CDC42EP1 LPIN3 STOX2 MTOR PAK1 KIF14 HELZ MARK2 SMAP2 SH3RF3 CRTC2 | 4.02e-05 | 1248 | 168 | 25 | int:YWHAG |
| Interaction | MYH9 interactions | DCAF15 ARHGAP24 GBF1 HDAC5 TCOF1 NTRK1 CAPZB KDM3B NASP WNK1 CREBBP USP2 RNF125 KIF14 MICAL3 FLOT1 NNT ALK | 6.10e-05 | 754 | 168 | 18 | int:MYH9 |
| Interaction | FBXO42 interactions | MAP1A TTC28 ERC1 WNK1 ARFGEF3 YEATS2 PIP4K2A KIF14 HELZ PRRC2B | 6.56e-05 | 259 | 168 | 10 | int:FBXO42 |
| Interaction | BAG2 interactions | ASXL1 ZNF609 ABL2 HDAC5 TCF20 NTRK1 CAPZB DNAJB6 KDM3B WNK1 DNAJC6 CREBBP URGCP YEATS2 KIF14 SMAP2 | 6.72e-05 | 622 | 168 | 16 | int:BAG2 |
| Interaction | IRF1 interactions | 6.81e-05 | 83 | 168 | 6 | int:IRF1 | |
| Interaction | PHF20 interactions | 7.88e-05 | 53 | 168 | 5 | int:PHF20 | |
| Interaction | EGR2 interactions | 9.59e-05 | 171 | 168 | 8 | int:EGR2 | |
| Interaction | PCGF3 interactions | 1.07e-04 | 90 | 168 | 6 | int:PCGF3 | |
| Interaction | YWHAB interactions | DAB2IP GBF1 ABL2 HDAC5 TTC28 ERC1 NTRK1 CAPZB BAX GCKR WNK1 TRIP12 CDC42EP1 LPIN3 STOX2 SLC9A1 MTOR KIF14 MARK2 SH3RF3 CRTC2 | 1.11e-04 | 1014 | 168 | 21 | int:YWHAB |
| Interaction | TRIM46 interactions | 1.23e-04 | 31 | 168 | 4 | int:TRIM46 | |
| Interaction | RERE interactions | 1.29e-04 | 93 | 168 | 6 | int:RERE | |
| Interaction | CSDE1 interactions | ARHGAP24 GBF1 NTRK1 CAPZB WNK1 ARFGEF3 FAM120A KIF14 LSM14B PRRC2B | 1.40e-04 | 284 | 168 | 10 | int:CSDE1 |
| Interaction | CDIN1 interactions | 1.78e-04 | 34 | 168 | 4 | int:CDIN1 | |
| Interaction | HCFC1 interactions | ASXL1 ARHGAP24 HDAC5 NTRK1 KANSL3 YEATS2 ZNF608 MBD5 MGA HCFC1 | 1.81e-04 | 293 | 168 | 10 | int:HCFC1 |
| Interaction | GAK interactions | 1.91e-04 | 189 | 168 | 8 | int:GAK | |
| Interaction | ALDH18A1 interactions | 1.91e-04 | 189 | 168 | 8 | int:ALDH18A1 | |
| Interaction | FUBP3 interactions | ARHGAP40 NTRK1 CAPZB FAM120A YLPM1 KIF14 HELZ LSM14B SMAP2 PRRC2B | 2.01e-04 | 297 | 168 | 10 | int:FUBP3 |
| Interaction | SMAD1 interactions | 2.08e-04 | 243 | 168 | 9 | int:SMAD1 | |
| Interaction | NIN interactions | TTC28 TRIO ERC1 PKP4 CAPZB DNAJB6 BAX ARFGEF3 KIF14 FLOT1 MGA | 2.20e-04 | 359 | 168 | 11 | int:NIN |
| Interaction | TERF2IP interactions | ZNF609 TCF20 KDM3B NASP MED1 TRIP12 CREBBP KANSL3 YEATS2 ZNF608 CFDP1 MLH1 MGA HCFC1 | 2.24e-04 | 552 | 168 | 14 | int:TERF2IP |
| Interaction | WWTR1 interactions | TCF20 TTC28 ERC1 CAPZB MPDZ CREBBP BRAP YEATS2 SND1 SEC23IP HCFC1 PRRC2B | 2.27e-04 | 422 | 168 | 12 | int:WWTR1 |
| Interaction | MARK3 interactions | 2.28e-04 | 246 | 168 | 9 | int:MARK3 | |
| Interaction | XRCC6 interactions | ASXL1 ARHGAP24 HDAC5 TCF20 NTRK1 CAPZB BAX NASP KAT2A MED1 TRIP12 CREBBP GTF2E1 YLPM1 CFDP1 KIF14 MBD5 MGA HCFC1 | 2.78e-04 | 928 | 168 | 19 | int:XRCC6 |
| Interaction | E2F1 interactions | 2.81e-04 | 200 | 168 | 8 | int:E2F1 | |
| Interaction | PRPS2 interactions | 2.81e-04 | 253 | 168 | 9 | int:PRPS2 | |
| Interaction | PCNA interactions | ASXL1 KRT7 PMS2 ERCC6 HDAC5 TCOF1 NTRK1 USP37 CREBBP USP2 MTOR SEC23IP MLH1 | 2.81e-04 | 497 | 168 | 13 | int:PCNA |
| Interaction | PTF1A interactions | 2.94e-04 | 16 | 168 | 3 | int:PTF1A | |
| Interaction | KANSL2 interactions | 2.96e-04 | 70 | 168 | 5 | int:KANSL2 | |
| Interaction | MAPK8IP3 interactions | 2.96e-04 | 70 | 168 | 5 | int:MAPK8IP3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q35 | 1.25e-04 | 129 | 170 | 5 | chr2q35 | |
| Cytoband | 12p13.3 | 1.88e-04 | 30 | 170 | 3 | 12p13.3 | |
| Cytoband | 20q11 | 2.02e-04 | 6 | 170 | 2 | 20q11 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.18e-06 | 181 | 114 | 9 | 694 | |
| GeneFamily | ATAC complex | 6.67e-05 | 13 | 114 | 3 | 1058 | |
| GeneFamily | MutL homologs | 2.35e-04 | 4 | 114 | 2 | 1027 | |
| GeneFamily | Acyl-CoA synthetase family | 5.71e-04 | 26 | 114 | 3 | 40 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 1.08e-03 | 8 | 114 | 2 | 837 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA | TRIM46 CELF5 CELF4 KCTD8 MUC19 MUC16 CASZ1 ANKRD36B STOX2 CSRNP3 RTL9 NAV3 ROBO2 FGF13 CTNNA2 ACSL5 | 1.99e-07 | 506 | 169 | 16 | M39067 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | ASXL1 GBF1 ERC1 USP37 WNK1 CREBBP YEATS2 FAM120A KIF14 HCFC1 | 2.83e-07 | 180 | 169 | 10 | M8239 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ASXL1 DPYD GBF1 TTC28 TRIO ERC1 PKP4 DNAJB6 KDM3B ID1 MED1 TRIP12 CREBBP C2CD5 NFKB1 PIP4K2A NAV3 KIF14 HELZ MICAL3 | 7.22e-07 | 856 | 169 | 20 | M4500 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | TRIM46 CELF5 ACSL6 BNC2 CELF4 ERC1 KCTD8 MUC19 NBEA DNAJC6 CASZ1 ANKRD36B ARFGEF3 RNF125 CSRNP3 ROBO2 FGF13 FGF14 | 7.38e-07 | 703 | 169 | 18 | M39070 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HSERT | TRIM46 CELF5 ACSL6 GLT8D2 CELF4 ERC1 DNAJC6 CASZ1 ARFGEF3 CSRNP3 ROBO2 FGF13 FGF14 TNS1 | 1.44e-06 | 450 | 169 | 14 | M39072 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | TRIM46 CELF5 ACSL6 CELF4 ARHGAP24 MUC19 NBEA DNAJC6 CASZ1 C2CD5 ANKRD36B ARFGEF3 STOX2 CSRNP3 NAV3 ROBO2 MICAL3 FGF14 ANKRD36 CTNNA2 PRRC2B BRWD1 | 2.77e-06 | 1106 | 169 | 22 | M39071 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | CELF5 ACSL6 BNC2 CELF4 KCTD8 NBEA DNAJC6 C2CD5 ANKRD36B RNF125 CSRNP3 NAV3 ROBO2 FGF13 CTNNA2 | 6.25e-06 | 584 | 169 | 15 | M39068 |
| Coexpression | GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | 6.39e-06 | 200 | 169 | 9 | M291 | |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 1.96e-05 | 176 | 169 | 8 | M39223 | |
| Coexpression | GSE29949_DC_BRAIN_VS_MONOCYTE_BONE_MARROW_UP | 4.71e-05 | 199 | 169 | 8 | M8418 | |
| Coexpression | GSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_DN | 4.88e-05 | 200 | 169 | 8 | M7658 | |
| Coexpression | GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_DN | 4.88e-05 | 200 | 169 | 8 | M6583 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 5.19e-08 | 190 | 170 | 9 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 5.67e-08 | 192 | 170 | 9 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 5.93e-08 | 193 | 170 | 9 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 6.48e-08 | 195 | 170 | 9 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 7.38e-08 | 198 | 170 | 9 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.05e-08 | 200 | 170 | 9 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.05e-08 | 200 | 170 | 9 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.05e-08 | 200 | 170 | 9 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.94e-07 | 181 | 170 | 8 | 7f99002a6411117cc2361334c7c9228e20c574b4 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 6.32e-07 | 187 | 170 | 8 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 6.32e-07 | 187 | 170 | 8 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.42e-07 | 191 | 170 | 8 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.71e-07 | 192 | 170 | 8 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.34e-07 | 194 | 170 | 8 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.34e-07 | 194 | 170 | 8 | 15224fb3e7ca5bd1fb8c41f8275842f737014095 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 9.01e-07 | 196 | 170 | 8 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.01e-07 | 196 | 170 | 8 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.36e-07 | 197 | 170 | 8 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.36e-07 | 197 | 170 | 8 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.36e-07 | 197 | 170 | 8 | 5593721407f61fc5bc3f2f8bf8fa2604c4e29565 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 9.36e-07 | 197 | 170 | 8 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 9.72e-07 | 198 | 170 | 8 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.72e-07 | 198 | 170 | 8 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.72e-07 | 198 | 170 | 8 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.05e-06 | 200 | 170 | 8 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.05e-06 | 200 | 170 | 8 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.05e-06 | 200 | 170 | 8 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.05e-06 | 200 | 170 | 8 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.05e-06 | 200 | 170 | 8 | 85c0f038bcfb42669dca2b80273b0f8a1421405e | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.98e-06 | 152 | 170 | 7 | fed80b467ec9e30c7f98bed6cc4f8c583b715e9e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.56e-06 | 158 | 170 | 7 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 7.00e-06 | 184 | 170 | 7 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.51e-06 | 186 | 170 | 7 | 1850583d23903d08226aeb0edb3e07b0994330e4 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-myofibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.05e-06 | 188 | 170 | 7 | 116ca07ee4413dcc0e9e5ac99bfee6ed7b7847c6 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.33e-06 | 189 | 170 | 7 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.33e-06 | 189 | 170 | 7 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.55e-06 | 193 | 170 | 7 | bbea475d2c4c7b29674ff302529f8f83dd666dcb | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.55e-06 | 193 | 170 | 7 | a189d46c39067b717509cd144e0225cc93d7731d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.55e-06 | 193 | 170 | 7 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.88e-06 | 194 | 170 | 7 | 5cd72330c9d9bb21b6c9d5d35085eade101486d1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.02e-05 | 195 | 170 | 7 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 195 | 170 | 7 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.02e-05 | 195 | 170 | 7 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 1.02e-05 | 195 | 170 | 7 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.02e-05 | 195 | 170 | 7 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.06e-05 | 196 | 170 | 7 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-05 | 196 | 170 | 7 | e02301642243df483fd066d978317c113c04692b | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-05 | 197 | 170 | 7 | b9478212f14b7888e3abac02995177974ac3bd17 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.09e-05 | 197 | 170 | 7 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-05 | 197 | 170 | 7 | a1ae1aa797762a3768e14434c7e5cd19c595ecb3 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-05 | 198 | 170 | 7 | 688b0eb5534dde40b8630ab8a3252c816711e02e | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.13e-05 | 198 | 170 | 7 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 1.13e-05 | 198 | 170 | 7 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 1.17e-05 | 199 | 170 | 7 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.17e-05 | 199 | 170 | 7 | a09292de4c4447b8eee55d401808e43b817321cc | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.17e-05 | 199 | 170 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.20e-05 | 200 | 170 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.20e-05 | 200 | 170 | 7 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.20e-05 | 200 | 170 | 7 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.20e-05 | 200 | 170 | 7 | ed093626a9cac7531a2bf02f6e345c5e84b8c060 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.20e-05 | 200 | 170 | 7 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-05 | 152 | 170 | 6 | 77b319f594d5e4df29034bbf69c7490076f89dd3 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.14e-05 | 157 | 170 | 6 | 516903469756c5fabfdf56d7bd59b3bdd7b44e39 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-05 | 158 | 170 | 6 | 1d78578dc1f8ba43dacdccae1082c0b9d749f64d | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-05 | 160 | 170 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-05 | 160 | 170 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | frontal_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Ctla2a|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.29e-05 | 166 | 170 | 6 | 27af6c906cff1d40d134f0386db7708869691121 | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.58e-05 | 168 | 170 | 6 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial-N_cells_(NTS+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.90e-05 | 170 | 170 | 6 | 02f0be0aab8ba2d35a83238609352ef3677511c9 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.57e-05 | 174 | 170 | 6 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.57e-05 | 174 | 170 | 6 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.32e-05 | 178 | 170 | 6 | 15a99080e9f669572ab6d82934f324e6714846c1 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.32e-05 | 178 | 170 | 6 | 200308e109abb7e6f8816a6f8cce6d56862d4098 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.52e-05 | 179 | 170 | 6 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.72e-05 | 180 | 170 | 6 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.93e-05 | 181 | 170 | 6 | fb4df9a128761abe5c6310a30d7b2f7f2fdef46d | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.93e-05 | 181 | 170 | 6 | 566249e04dd491e6287ad2101b7b1ab11031ed8b | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.93e-05 | 181 | 170 | 6 | db9528dc7cb0230e4c36cb27da69102c588c7ee9 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.15e-05 | 182 | 170 | 6 | be32b5b8153c1053cbb55f1fccfa27c3ee97c1e1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.15e-05 | 182 | 170 | 6 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.15e-05 | 182 | 170 | 6 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.15e-05 | 182 | 170 | 6 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 7.37e-05 | 183 | 170 | 6 | 310ad42b2b5d8ddd01d3a12db338f80ac1f5d08e | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 7.59e-05 | 184 | 170 | 6 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.82e-05 | 185 | 170 | 6 | d9be5853acdda7b1ac819cf50c7940d1d2362d15 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.82e-05 | 185 | 170 | 6 | 1ac6a32cc56d5d819649bdd99518e2ead0eead4c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.06e-05 | 186 | 170 | 6 | 4dafc215c42e7949f932a3627359c107943b5d6b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.06e-05 | 186 | 170 | 6 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.30e-05 | 187 | 170 | 6 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-05 | 187 | 170 | 6 | df0279b7e94e26f5541b0e2a0ce56befa96ec8ca | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 8.30e-05 | 187 | 170 | 6 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | COPD-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 8.30e-05 | 187 | 170 | 6 | 030af361f8bdcd0aff4ec1922702833325cf74d8 | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-05 | 187 | 170 | 6 | fe9fc21192ede2eea61f419d20ccda254569d0a6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.54e-05 | 188 | 170 | 6 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.80e-05 | 189 | 170 | 6 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.06e-05 | 190 | 170 | 6 | 989d4eefd22d66ecb857836f8fdbcf41e3047f84 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.06e-05 | 190 | 170 | 6 | b94df372bc08de11585b2467dba8c8fffff5cd92 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.06e-05 | 190 | 170 | 6 | c8370c922e0cf0e0c36e02e1ed2b4053ad6a8073 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 9.06e-05 | 190 | 170 | 6 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.06e-05 | 190 | 170 | 6 | 5174f91a880f85bb20806023aa68bd4b8ca24ea5 | |
| Drug | Etoposide [33419-42-0]; Down 200; 6.8uM; PC3; HT_HG-U133A | ZNF609 TBC1D30 TRIO UBN1 SND1 NAV3 MICAL3 TNS1 HCFC1 ACSL5 BRWD1 | 3.02e-07 | 198 | 170 | 11 | 6681_DN |
| Drug | Pilocarpine nitrate [148-72-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A | ZNF609 GBF1 ABCA12 CAPZB STAT5B SLC9A1 RNF125 NNT HCFC1 PRRC2B | 2.29e-06 | 196 | 170 | 10 | 5341_UP |
| Disease | Colorectal Carcinoma | TBX22 DPYD PMS2 ERCC6 TCOF1 ABCA12 MCF2L2 AKAP3 WNK1 MYLK3 CSRNP3 ABCA6 MLH1 ABCC2 ACSL5 | 1.03e-05 | 702 | 165 | 15 | C0009402 |
| Disease | smoking status measurement, chronic obstructive pulmonary disease | 1.04e-05 | 88 | 165 | 6 | EFO_0000341, EFO_0006527 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 4.85e-05 | 169 | 165 | 7 | DOID:3908 (is_marker_for) | |
| Disease | QT interval | ARHGAP24 GBF1 HDAC5 MCF2L2 CREBBP CASZ1 PTPRG PIP4K2A FGF14 MBD5 PRRC2B BRWD1 | 5.04e-05 | 534 | 165 | 12 | EFO_0004682 |
| Disease | JT interval | 8.21e-05 | 248 | 165 | 8 | EFO_0007885 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 8.62e-05 | 128 | 165 | 6 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 8.62e-05 | 128 | 165 | 6 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 8.62e-05 | 128 | 165 | 6 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 8.62e-05 | 128 | 165 | 6 | C1306837 | |
| Disease | Renal Cell Carcinoma | 8.62e-05 | 128 | 165 | 6 | C0007134 | |
| Disease | ovarian neoplasm | 1.11e-04 | 134 | 165 | 6 | C0919267 | |
| Disease | Malignant neoplasm of ovary | 1.25e-04 | 137 | 165 | 6 | C1140680 | |
| Disease | feeling nervous measurement | 1.31e-04 | 87 | 165 | 5 | EFO_0009597 | |
| Disease | depressive symptom measurement | 1.52e-04 | 426 | 165 | 10 | EFO_0007006 | |
| Disease | middle cerebral artery infarction (biomarker_via_orthology) | 1.80e-04 | 93 | 165 | 5 | DOID:3525 (biomarker_via_orthology) | |
| Disease | Constitutional Mismatch Repair Deficiency Syndrome | 1.85e-04 | 4 | 165 | 2 | C4321324 | |
| Disease | Turcot syndrome | 1.85e-04 | 4 | 165 | 2 | cv:C0265325 | |
| Disease | Lynch syndrome | 1.85e-04 | 4 | 165 | 2 | cv:C4552100 | |
| Disease | hereditary sensory neuropathy (is_implicated_in) | 1.85e-04 | 4 | 165 | 2 | DOID:0050548 (is_implicated_in) | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.91e-04 | 148 | 165 | 6 | C0279702 | |
| Disease | urate measurement, bone density | DAB2IP ARHGAP24 TTC28 ERC1 CASZ1 DNAH1 PTPRG KIF14 EIF2AK4 CTNNA2 SH3RF3 PRRC2B | 2.01e-04 | 619 | 165 | 12 | EFO_0003923, EFO_0004531 |
| Disease | acute lymphoblastic leukemia (is_implicated_in) | 2.57e-04 | 55 | 165 | 4 | DOID:9952 (is_implicated_in) | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 2.63e-04 | 157 | 165 | 6 | DOID:224 (biomarker_via_orthology) | |
| Disease | feeling emotionally hurt measurement | 2.76e-04 | 56 | 165 | 4 | EFO_0009599 | |
| Disease | Turcot syndrome (disorder) | 3.07e-04 | 5 | 165 | 2 | C0265325 | |
| Disease | dementia (biomarker_via_orthology) | 3.07e-04 | 5 | 165 | 2 | DOID:1307 (biomarker_via_orthology) | |
| Disease | probable ATP-dependent RNA helicase DHX58 measurement | 3.07e-04 | 5 | 165 | 2 | EFO_0802901 | |
| Disease | handedness | 3.31e-04 | 106 | 165 | 5 | EFO_0009902 | |
| Disease | microglial activation measurement | 3.38e-04 | 59 | 165 | 4 | EFO_0010940 | |
| Disease | Streptozotocin Diabetes | 3.61e-04 | 108 | 165 | 5 | C0038433 | |
| Disease | Diabetes Mellitus, Experimental | 3.61e-04 | 108 | 165 | 5 | C0011853 | |
| Disease | Alloxan Diabetes | 3.61e-04 | 108 | 165 | 5 | C0002152 | |
| Disease | visceral adipose tissue measurement | 3.98e-04 | 481 | 165 | 10 | EFO_0004765 | |
| Disease | cognitive function measurement | DPYD CELF4 GBF1 TCF20 TTC28 MCF2L2 NBEA CDH19 STOX2 ADRA1A FAM120A ZNF608 SND1 BARHL2 CFDP1 FGF13 CTNNA2 SH3RF3 ACSL5 | 4.40e-04 | 1434 | 165 | 19 | EFO_0008354 |
| Disease | arterial stiffness measurement | 4.61e-04 | 64 | 165 | 4 | EFO_0004517 | |
| Disease | mean arterial pressure | ARHGAP24 TCF20 PKP4 TRIP12 CASZ1 HOXA3 YEATS2 SLC9A1 EIF2AK4 TNS1 | 5.30e-04 | 499 | 165 | 10 | EFO_0006340 |
| Disease | Neoplasm of uncertain or unknown behavior of ovary | 5.64e-04 | 29 | 165 | 3 | C0496920 | |
| Disease | vital capacity | TRIM46 BNC2 MICAL1 TCF20 ERC1 CAPZB INO80 MED1 TRIP12 CASZ1 HOXA3 RTL9 ENTPD6 MICAL3 CTNNA2 TNS1 NNT | 5.88e-04 | 1236 | 165 | 17 | EFO_0004312 |
| Disease | neuroticism measurement | BNC2 ZNF609 CELF4 PKP4 CDH19 ATF6B IHO1 FAM120A PTPRG MICB PIP4K2A YLPM1 FGF14 MBD5 | 6.17e-04 | 909 | 165 | 14 | EFO_0007660 |
| Disease | Ovarian Carcinoma | 6.24e-04 | 30 | 165 | 3 | C0029925 | |
| Disease | perceived unattractiveness to mosquitos measurement | 7.21e-04 | 72 | 165 | 4 | EFO_0008380 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 8.27e-04 | 195 | 165 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | diet measurement | BNC2 DPYD CELF4 TCF20 TRIO KCTD8 KDM3B GCKR ZNF608 SND1 BARHL2 ROBO2 CTNNA2 MBD5 CRTC2 | 8.43e-04 | 1049 | 165 | 15 | EFO_0008111 |
| Disease | Lynch Syndrome | 1.09e-03 | 9 | 165 | 2 | C4552100 | |
| Disease | response to methylphenidate | 1.09e-03 | 9 | 165 | 2 | GO_0036271 | |
| Disease | stomach cancer (is_marker_for) | 1.25e-03 | 142 | 165 | 5 | DOID:10534 (is_marker_for) | |
| Disease | alcohol use disorder measurement | 1.33e-03 | 214 | 165 | 6 | EFO_0009458 | |
| Disease | gamma-glutamylthreonine measurement | 1.36e-03 | 10 | 165 | 2 | EFO_0021143 | |
| Disease | protein intake measurement | 1.36e-03 | 10 | 165 | 2 | EFO_0010810 | |
| Disease | Schizophrenia | ACSL6 DPYD NTRK1 BRAP ADRA1A MTOR PTPRZ1 MICB PIP4K2A CTNNA2 MARK2 KIF17 ALK | 1.45e-03 | 883 | 165 | 13 | C0036341 |
| Disease | lymphocyte count | GBF1 TTC28 NTRK1 BAX GCKR UROC1 TRIP12 CASZ1 STAT5B HOXA3 NFKB1 HELZ ROBO2 MICAL3 MICA FGF13 CHST2 GIMAP6 | 1.46e-03 | 1464 | 165 | 18 | EFO_0004587 |
| Disease | photoreceptor cell layer thickness measurement | 1.50e-03 | 148 | 165 | 5 | EFO_0803370 | |
| Disease | fibroblast growth factor 21 measurement | 1.65e-03 | 11 | 165 | 2 | EFO_0010783 | |
| Disease | interleukin-6 measurement, response to stimulus | 1.65e-03 | 11 | 165 | 2 | EFO_0004810, GO_0050896 | |
| Disease | forced expiratory volume | BNC2 MICAL1 ARHGAP24 INO80 MED1 CASZ1 HOXA3 CFDP1 MICAL3 TNS1 NNT PRRC2B | 1.68e-03 | 789 | 165 | 12 | EFO_0004314 |
| Disease | Secondary Biliary Cholangitis | 1.68e-03 | 42 | 165 | 3 | C0238065 | |
| Disease | Biliary cirrhosis | 1.68e-03 | 42 | 165 | 3 | C0023892 | |
| Disease | Biliary Cirrhosis, Primary, 1 | 1.68e-03 | 42 | 165 | 3 | C4551595 | |
| Disease | progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian serous carcinoma | 1.68e-03 | 42 | 165 | 3 | EFO_0004920, EFO_1001516, GO_0097328, MONDO_0009354 | |
| Disease | alcohol consumption measurement | COL12A1 NBEA GCKR MED1 PHC2 STOX2 ZNF608 SND1 MTOR CFDP1 MICAL3 FGF14 ANKRD36 CTNNA2 MGA SNTB2 | 1.68e-03 | 1242 | 165 | 16 | EFO_0007878 |
| Disease | Colonic Neoplasms | 1.68e-03 | 152 | 165 | 5 | C0009375 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | BNC2 TCF20 TTC28 NBEA PHC2 SND1 BARHL2 HELZ ROBO2 CTNNA2 PRRC2B BRWD1 | 1.90e-03 | 801 | 165 | 12 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | colorectal cancer (is_marker_for) | 1.94e-03 | 157 | 165 | 5 | DOID:9256 (is_marker_for) | |
| Disease | social interaction measurement | 1.94e-03 | 94 | 165 | 4 | EFO_0009592 | |
| Disease | age at menarche | DPYD ARHGAP40 TTC28 KCTD8 KDM3B INO80 DNAJC6 PTPRG SEC23IP BRWD1 | 1.96e-03 | 594 | 165 | 10 | EFO_0004703 |
| Disease | mismatch repair cancer syndrome (is_implicated_in) | 1.98e-03 | 12 | 165 | 2 | DOID:0112182 (is_implicated_in) | |
| Disease | phosphatidylcholine 34:4 measurement | 1.98e-03 | 12 | 165 | 2 | EFO_0010378 | |
| Disease | Malignant tumor of colon | 2.05e-03 | 159 | 165 | 5 | C0007102 | |
| Disease | Adenocarcinoma of large intestine | 2.10e-03 | 96 | 165 | 4 | C1319315 | |
| Disease | pulse pressure measurement | BNC2 ARHGAP24 TTC28 NBEA INO80 CASZ1 PHC2 STAT5B HOXA3 SND1 PIP4K2A CFDP1 EIF2AK4 CTNNA2 MBD5 NNT HCFC1 | 2.12e-03 | 1392 | 165 | 17 | EFO_0005763 |
| Disease | smoking status measurement | BNC2 DPYD CELF4 GBF1 TCF20 PHC2 PTPRG CSRNP3 BARHL2 ENTPD6 ROBO2 CTNNA2 ALK PRRC2B BRWD1 | 2.26e-03 | 1160 | 165 | 15 | EFO_0006527 |
| Disease | Liver carcinoma | 2.30e-03 | 507 | 165 | 9 | C2239176 | |
| Disease | Primary biliary cirrhosis | 2.32e-03 | 47 | 165 | 3 | C0008312 | |
| Disease | neutrophil percentage of leukocytes | 2.37e-03 | 610 | 165 | 10 | EFO_0007990 | |
| Disease | pancreatic cancer (is_marker_for) | 2.53e-03 | 101 | 165 | 4 | DOID:1793 (is_marker_for) | |
| Disease | blood cobalt measurement | 2.53e-03 | 101 | 165 | 4 | EFO_0007577 | |
| Disease | gastroesophageal reflux disease | 2.53e-03 | 101 | 165 | 4 | EFO_0003948 | |
| Disease | overall survival, pancreatic carcinoma | 2.62e-03 | 49 | 165 | 3 | EFO_0000638, EFO_0002618 | |
| Disease | Childhood Ataxia with Central Nervous System Hypomyelinization | 2.71e-03 | 14 | 165 | 2 | C1858991 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 2.78e-03 | 50 | 165 | 3 | EFO_0022334 | |
| Disease | platelet crit | MAP1A TTC28 CAPZB BAX GCKR C2CD5 BRAP LPIN3 MICB YLPM1 NAV3 CHST2 LY75 | 2.78e-03 | 952 | 165 | 13 | EFO_0007985 |
| Disease | BMI-adjusted leptin measurement | 3.11e-03 | 15 | 165 | 2 | EFO_0007793 | |
| Disease | Tinnitus, response to cisplatin | 3.11e-03 | 15 | 165 | 2 | GO_0072718, HP_0000360 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 3.11e-03 | 15 | 165 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | Rhabdomyosarcoma | 3.11e-03 | 15 | 165 | 2 | C0035412 | |
| Disease | C-reactive protein measurement | BNC2 DPYD MAP1A KCTD8 GCKR DNAJC6 TRIP12 IL22RA1 YEATS2 ZNF608 ABCA6 NFKB1 ENTPD6 MICAL3 GIMAP6 | 3.26e-03 | 1206 | 165 | 15 | EFO_0004458 |
| Disease | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3.28e-03 | 53 | 165 | 3 | C1961099 | |
| Disease | urinary albumin to creatinine ratio | 3.41e-03 | 179 | 165 | 5 | EFO_0007778 | |
| Disease | T-Cell Lymphoma | 3.54e-03 | 16 | 165 | 2 | C0079772 | |
| Disease | nervousness | 3.54e-03 | 16 | 165 | 2 | NCIT_C74532 | |
| Disease | Idiopathic pulmonary arterial hypertension | 3.54e-03 | 16 | 165 | 2 | C3203102 | |
| Disease | coffee consumption measurement | 3.66e-03 | 182 | 165 | 5 | EFO_0006781 | |
| Disease | Intellectual Disability | 3.79e-03 | 447 | 165 | 8 | C3714756 | |
| Disease | total blood protein measurement | 3.90e-03 | 449 | 165 | 8 | EFO_0004536 | |
| Disease | Night blindness, congenital stationary | 4.00e-03 | 17 | 165 | 2 | C0339535 | |
| Disease | Familial primary pulmonary hypertension | 4.00e-03 | 17 | 165 | 2 | C0340543 | |
| Disease | reaction time measurement | 4.05e-03 | 658 | 165 | 10 | EFO_0008393 | |
| Disease | lymphocyte percentage of leukocytes | 4.36e-03 | 665 | 165 | 10 | EFO_0007993 | |
| Disease | brain infarction | 4.48e-03 | 18 | 165 | 2 | EFO_0004277 | |
| Disease | Malignant neoplasm of endometrium | 4.48e-03 | 18 | 165 | 2 | C0007103 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GQVGSSSPKRSGMTA | 331 | Q99569 | |
| SMATGMGPSSSGSQA | 491 | P23470 | |
| GGSFSSSQPIGMTKI | 96 | Q8NAP1 | |
| MASASSPASSGGSGK | 566 | Q7Z569 | |
| KSDPSGHLTGMVGTA | 891 | Q9P2K8 | |
| SSISPAKMANGTAGT | 1051 | P42684 | |
| GSLMFSSLSGSNGGI | 1021 | Q6ZN30 | |
| AAGNTISMPTASGAK | 1386 | Q86V15 | |
| TSGTTGNPKGAMVTH | 276 | P33121 | |
| LLGPNGAGKTTTISM | 1376 | Q86UK0 | |
| APAGGSGMASAKTKT | 241 | P35348 | |
| PNGAGKSSSIRMISG | 1321 | Q8N139 | |
| SAMGKSPLSQGDSSA | 116 | Q92793 | |
| NTVSGLMGLKSDGTP | 736 | Q12882 | |
| TRIMGGGKSGTVSSQ | 636 | A6QL64 | |
| TRIMGGGKSGTVSSQ | 346 | Q8N2N9 | |
| SLSMGAKSAGSLRPS | 566 | Q8IV53 | |
| KSGSGTMNLGGSLTR | 181 | P47756 | |
| MGTVLSLSPASSAKG | 1 | Q13319 | |
| NSSGTGKTSMPSGDE | 1131 | Q03468 | |
| SKAEAGMGATGSVQP | 776 | Q5H9R4 | |
| SKAGAGMDTRGSAQP | 816 | Q5H9R4 | |
| SLHGLGKNSGMVDGS | 1151 | Q8IXJ9 | |
| GKNSGMVDGSSPSSL | 1156 | Q8IXJ9 | |
| GKLGPSTNSMSGGVQ | 1336 | Q8IXJ9 | |
| KLGSSFPSTPSSDGM | 636 | O60312 | |
| GSETPKSTMTLGRSG | 81 | Q8IUD2 | |
| IFSPSMGGGSNSSLS | 406 | Q92830 | |
| LGETSGAGSSGMLNT | 81 | Q9ULG1 | |
| NSGPAGGSKEMGTSS | 106 | P50221 | |
| GFQPLMSDLGSTGST | 366 | Q29983 | |
| STMKTGPLISSSQGR | 541 | Q9NRJ5 | |
| PGSGSSSISAGLQKM | 671 | Q5VWQ8 | |
| PGGSALISNLGKVMS | 671 | P51610 | |
| GSMAVASTNIPIGKG | 1031 | Q8WXI7 | |
| MPLTTGSQGMASSGG | 2786 | Q8WXI7 | |
| GSAEMTITPKTGHSG | 8781 | Q8WXI7 | |
| TQSSGDMGLPPASKS | 331 | Q9BQK8 | |
| MKVASGSTATAAAGP | 1 | P41134 | |
| LGGNSKTAMIATISP | 666 | Q15058 | |
| ATVMKSGGLPSLGLT | 236 | P04629 | |
| MALKDTGSGGSTILP | 1 | Q6ZWB6 | |
| SGLGLHGSSSNMKTL | 1426 | Q7RTP6 | |
| AGPMALSSKGSSGAP | 2676 | P78559 | |
| KGLGDMAVSSSVGSN | 996 | O60721 | |
| MSGESARSLGKGSAP | 1 | P78417 | |
| KGKGMLTSSGGQSPS | 251 | O43365 | |
| SKMASSSGTATNRPG | 1501 | Q8IWI9 | |
| MGSNALSFSSSAGPG | 436 | P08729 | |
| MLSIPSGSGNKKSSN | 11 | Q8IYA8 | |
| MSGSSGTPYLGSKIS | 1 | Q9BX40 | |
| FTSVPSQGGSTLGMS | 81 | Q8WYN3 | |
| PQFEMSTSKGSGAGS | 966 | Q86YR7 | |
| NKITLVSSGSGTMGA | 376 | O75955 | |
| VSSGSGTMGAAKVTG | 381 | O75955 | |
| FSAGSGCGRPSSNKM | 121 | C9JC47 | |
| PSKNGSMTTALGSQL | 7781 | Q7Z5P9 | |
| MSGTSKESLGHGGLP | 1 | Q32MK0 | |
| GFKKPSGVGSSAMIT | 1066 | Q8IVL0 | |
| SKSTSASAIMNGGKP | 226 | Q92915 | |
| MSGDATRTLGKGSQP | 1 | Q9H4Y5 | |
| LGSALTSGGPSLSAM | 706 | Q7LBC6 | |
| PASPGGCVAMSTGKS | 591 | O60449 | |
| DKTDTGMPATGSAGT | 496 | Q8TDZ2 | |
| SSSLGGGVATSPMLI | 261 | Q9H1C3 | |
| GPVGSGKSSLISAML | 671 | Q92887 | |
| RKSSMTLGAGGSSPS | 496 | Q9NSB4 | |
| GFQPLMSATGSTGST | 366 | Q29980 | |
| SGSQLAEGKGSQMGT | 511 | Q9NZB2 | |
| TGMDRSPGKSPSANG | 1496 | P23471 | |
| SSSPQSSAGGKPAMS | 1881 | P42694 | |
| GSLMNGPSFTSKGTK | 696 | A8MWY0 | |
| GGGSSVSMIASRKPT | 686 | P49321 | |
| PEGLSGSSRMKGGSA | 251 | Q14397 | |
| TLKSGSKDPGMTGSS | 741 | O43182 | |
| STMIGAGSKDAGTLN | 21 | Q13153 | |
| SMNNGSPTALSGSKT | 386 | Q8N264 | |
| GGSGMGNFKSISTST | 181 | O75190 | |
| AAAMTSLKGQPSISG | 1876 | Q9P2D7 | |
| GGGSRMTDLTSSIPK | 11 | Q9NR50 | |
| SLPAGSGLKRSSGMS | 211 | Q9UEE9 | |
| GAPIGSGSSDSSMLD | 846 | P26232 | |
| MGEGKLRQGSGTTAS | 1071 | Q99715 | |
| GSGKTATMTLPDTEG | 351 | Q8WW52 | |
| MATSGANGPGSATAS | 1 | Q53ET0 | |
| GGPTSSEQIMKTGAL | 11 | Q07812 | |
| LSTPLTGRMAGSSKG | 876 | Q5TH69 | |
| GSQTMPGASSSLVVK | 196 | Q8N6W0 | |
| MTQSGKSSAGNILLG | 16 | P0DJR0 | |
| GGFGMGSKSAATSPT | 646 | O75061 | |
| GGRGAATMSLGKLSP | 6 | Q00587 | |
| TSGTTGDPKGAMITH | 261 | Q9ULC5 | |
| ALTSGTIKAMLSGPG | 36 | Q15369 | |
| GSITSLQFSPMAKGS | 271 | Q9NSI6 | |
| ILSSASSGSPGMMNG | 16 | Q9NY43 | |
| NGKDSLTMPGSRAST | 501 | Q7KZI7 | |
| AGSSSVKSQPGLLGM | 546 | Q9P267 | |
| SRSVSGVLNGGKSMS | 226 | Q92913 | |
| CMEGSGKDSPTGTLS | 406 | Q8N6P7 | |
| TPNGTTLSSNLTGGM | 251 | Q92538 | |
| AAGGKPITMTLGQAS | 671 | Q9P2N6 | |
| DSGSANPKGGISSKM | 1241 | Q9ULL0 | |
| GTLTGKFMSTSSIPG | 411 | Q9UQL6 | |
| PDDMKGISGGSSSSS | 541 | Q15835 | |
| LSLTPKTGMGSGSAG | 311 | Q86YS7 | |
| AKDMIGQPGALSGTT | 226 | Q9H159 | |
| MAPSSKSERNSGAGS | 1 | Q66K64 | |
| AKSPISSGSGGSHMS | 1221 | Q15648 | |
| SGMKSSSGLGSSGSL | 1241 | Q15648 | |
| MATPGNLGSSVLASK | 1 | P48426 | |
| ARMSSPALTAGASGK | 141 | Q8N323 | |
| GQTGSGKSFTMQGLP | 91 | Q9P2E2 | |
| GLMGFGTSPSPAKST | 341 | P42345 | |
| STAGGKPMEISGTHT | 896 | Q13423 | |
| IASAPGSKMSQSGSP | 1121 | P0C091 | |
| GSKMSQSGSPISAFS | 1126 | P0C091 | |
| PATGAMSIATTKSAG | 291 | Q8TC56 | |
| STAMNESSSGKAGKP | 246 | Q9BY42 | |
| SGNMSTLQKTVPASG | 421 | Q8NET4 | |
| KTSSAMAGSVGAAAP | 331 | P29083 | |
| IGMGKILLGSGASSN | 656 | Q7Z4K8 | |
| AKPGMVSAGQADSSS | 186 | Q13428 | |
| TGSLKTPGGSSVGML | 236 | O75354 | |
| MGKTGSGKSATGNSI | 46 | Q6P9H5 | |
| RSGSSGGQQPSGMKE | 71 | Q9BRQ6 | |
| GLSSQTTGAKGGMEI | 986 | Q8NFP9 | |
| STPSTQGQGKGAMGT | 291 | Q6ZNE9 | |
| MASSAQSGGSSGGPA | 1 | Q7KZF4 | |
| GSSPAGSLADAMSQK | 126 | P51692 | |
| MSKGSGASFESPLNS | 136 | Q8TE99 | |
| MAERKPNGGSGGAST | 1 | Q9Y6Y8 | |
| GLAGPSGEMVKSTTS | 351 | P40692 | |
| SSQETSKGLGPNMSS | 866 | P55201 | |
| SEGTSPGSKMALQSS | 426 | Q9UM73 | |
| TPGALSGLTKMAVSQ | 646 | O75969 | |
| TSGTTGNPKGAMLTH | 276 | Q9UKU0 | |
| GLAAAPMTPTSGGST | 306 | Q9BZC1 | |
| VQISMGPSLDGSSGK | 221 | Q99941 | |
| LNMTSGSGSSSKPFV | 456 | Q9Y4C5 | |
| DSTGPTPRSSGGTKM | 356 | Q96F05 | |
| PGTGKSTLLNTMFGL | 701 | Q8TCY9 | |
| GTGSTNKNLPIMSTA | 21 | A0AVT1 | |
| LSSPGMTSGNGNSAS | 531 | Q8IXK0 | |
| GSGGMSLFLSKAVGS | 256 | Q9BVS5 | |
| DSGMKGAQLSSGASK | 141 | Q5TG30 | |
| MGSVLSTDSGKSAPA | 1 | Q96EQ8 | |
| SSLGMTVSANKDGLG | 1016 | O75970 | |
| NMGTPVSSCPGGTKS | 791 | Q9NXC5 | |
| SSLARIGGSGMPGKA | 211 | Q8N7X1 | |
| RKVVGSMPTAGSAGS | 226 | Q8WU79 | |
| TSGLGGMSGAQAKAA | 246 | Q96N76 | |
| KGITTTMHPGSGSLS | 546 | Q8TEJ3 | |
| PMLSSLGVTNSKSGS | 411 | Q9Y458 | |
| SRSMDNSKGPLGASS | 491 | Q9P2F5 | |
| TKSTHGSLSGLGLMG | 746 | Q96IC2 | |
| MGQTALAGGSSSTPT | 1 | Q99619 | |
| VSSPVASGMSSPSGG | 1411 | Q9HBL0 | |
| MSLSSGASGGKGVDA | 1 | O15014 | |
| NSMGSATGPLPGTKV | 466 | O15014 | |
| SASPSGKPSGSAVNM | 2161 | Q5JSZ5 | |
| MASGSAGKPTGEAAS | 1 | Q9H1K6 | |
| SGGMGKIPSAVSTVS | 591 | P19634 | |
| NSTKPSATKGTLGGM | 306 | P08240 | |
| PGSSMDNLDSSVTGK | 1241 | Q9HCK4 | |
| QMSRSFSKPGGGNSG | 906 | Q9Y2I9 | |
| PGAMTSTTSQKPGSN | 1461 | Q9UGU0 | |
| STFPSKTGGMEGGTA | 956 | P49750 | |
| KTGGMEGGTAVATSS | 961 | P49750 | |
| PLGQKRGMLSSSTSG | 446 | P54278 | |
| QPGTAGGMRVSVSSK | 2086 | Q96AY4 | |
| MKPSQGSGSFGAILG | 111 | Q86T82 | |
| SPKLSGAMSSNSLGI | 1031 | Q9NPG3 | |
| APAAGNSGSTQGMKI | 1016 | Q9ULD9 | |
| MSGGAAEKQSSTPGS | 1 | Q9H4A3 | |
| SSPGRDGMNSKSAQG | 251 | O75604 | |
| NAMLGATSTAGGSKE | 311 | Q13425 | |
| TSPPKACTNGSGSMG | 941 | Q14669 | |
| TAGSNKTMVVSGAAG | 151 | Q8N8N7 | |
| MSGSSGGAAAPAASS | 1 | O75962 | |
| GPQKSGSQGSVMATL | 726 | Q9ULM3 | |
| GITFHPGTTKSNAGM | 416 | P19838 |